Structure of Shogaol
CAS No.: 555-66-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Shogaol is a naturally occuring pungent component of ginger with anti-inflammatory and anticancer properties.
Synonyms: [6]-Shogaol; 6-Shogaol
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 555-66-8 |
Formula : | C17H24O3 |
M.W : | 276.37 |
SMILES Code : | CCCCC/C=C/C(CCC1=CC=C(O)C(OC)=C1)=O |
Synonyms : |
[6]-Shogaol; 6-Shogaol
|
MDL No. : | MFCD01736094 |
InChI Key : | OQWKEEOHDMUXEO-BQYQJAHWSA-N |
Pubchem ID : | 5281794 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Caco-2 cells | 5, 10, 20 μg/mL | 24 hours | To investigate the effects of 6-shogaol on glucose uptake and intestinal barrier integrity in Caco-2 cells. Results showed that 6-shogaol inhibited glucose uptake, down-regulated the expression of glucose transporters GLUT2 and SGLT1, and up-regulated the expression of tight junction proteins ZO-1, Occludin, and Claudin. | Foods. 2023 Jan 21;12(3):503 |
R-CCRF-CEM (T-ALL) | 10-200 µM | 72 hours | To evaluate the effect of 6-shogaol on the viability of R-CCRF-CEM cells, results showed that 6-shogaol inhibited cell viability at higher concentrations. | J Cell Mol Med. 2021 May 3;25(13):6148–60 |
RN95 (B-ALL) | 10-200 µM | 72 hours | To evaluate the effect of 6-shogaol on the viability of RN95 cells, results showed that 6-shogaol inhibited cell viability at higher concentrations. | J Cell Mol Med. 2021 May 3;25(13):6148–60 |
CCRF-CEM (T-ALL) | 10-200 µM | 72 hours | To evaluate the effect of 6-shogaol on the viability of CCRF-CEM cells, results showed that 6-shogaol inhibited cell viability at higher concentrations. | J Cell Mol Med. 2021 May 3;25(13):6148–60 |
Nalm-6 (B-ALL) | 10-200 µM | 96 hours | To evaluate the effect of 6-shogaol on the viability of Nalm-6 cells, results showed that 6-shogaol significantly inhibited cell viability at higher concentrations. | J Cell Mol Med. 2021 May 3;25(13):6148–60 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
C57BL/6 male mice | Stress-induced IBS model | Gavage | 0.1 to 1 mg/kg | Once daily for 2 weeks | 6-Shogaol significantly increased the AWR score, number of defecation particles, and fecal water content of IBS mice in a dose-dependent manner, and increased inflammatory infiltration of the intestinal mucosa and inhibited the differentiation and regeneration of ICSCs | Research (Wash D C). 2024 Nov 7;7:0524 |
C57BL/6j male mice | Pressure-overload-induced heart failure model | Oral | 0.2 or 1 mg/kg | Once daily for 8 weeks | Prevented TAC-induced systolic dysfunction and cardiac hypertrophy, significantly inhibited TAC-induced increases in histone H3K9 acetylation | Nutrients. 2023 May 8;15(9):2232 |
Wistar rats | Rotenone-induced Parkinson's disease model | Oral | 10 and 20 mg/kg | Daily administration for 28 days | 6-Shogaol significantly improved rotenone-induced behavioral and biochemical abnormalities, including motor function, antioxidant status, inflammatory response, and neurotransmitter levels. | Pharmaceuticals (Basel). 2024 Oct 9;17(10):1348 |
Mice | Oxaliplatin-induced neuropathic pain model | Intraperitoneal injection | 10 mg/kg | Single injection, lasting for 3 hours | To evaluate the analgesic effect of [6]-Shogaol on oxaliplatin-induced cold and mechanical allodynia. Results showed that 10 mg/kg of [6]-Shogaol significantly alleviated oxaliplatin-induced cold and mechanical allodynia, lasting for 3 hours. | Pharmaceuticals (Basel). 2022 Jun 8;15(6):726 |
Mice | Oxaliplatin-induced neuropathic pain model | Intraperitoneal injection | 10 mg/kg | Single administration, evaluated after 1 hour | To evaluate the alleviating effect of [6]-Shogaol on oxaliplatin-induced cold and mechanical allodynia, results showed that [6]-Shogaol significantly alleviated pain. | Pharmaceuticals (Basel). 2023 Oct 15;16(10):1465 |
C57BL/6 mice | MPTP-induced Parkinson's disease model | Oral | 10 mg/kg/day | Once daily for 3 days | To investigate the protective effects of 6-shogaol against MPTP-induced movement impairment and dopaminergic neuronal damage. Results showed that 6-shogaol significantly improved motor coordination, increased the number of TH-positive cells in the substantia nigra pars compacta and TH-IR fiber intensity in the striatum, and inhibited microglial activation and increases in TNF-α, NO, iNOS, and COX-2 levels. | Acta Pharmacol Sin. 2013 Sep;34(9):1131-9 |
Swiss albino mice | Traumatic brain injury (TBI) model | Intraperitoneal injection | 10, 20 and 30 mg/kg/day | Once daily for 14 days | 6-Shogaol (higher dose) was able to attenuate anxiety/depression-like behaviors in mice with TBI. 6-Shogaol treatment also altered MDA formation and expressions of TNF-α and IL-1β that act as major inflammation-inducing cytokines in brain tissue. Additionally, brain BDNF levels were also affected by 6-Shogaol treatment. | ACS Omega. 2021 Dec 28;7(1):140-148 |
Mice | Pirt-GCaMP6s transgenic mice | Ex vivo gastroesophageal-vagal preparation | 100 μM | Pretreatment for 30 min followed by vincristine application for 30 min in presence of 6-shogaol | 6-shogaol attenuated vincristine-induced activation of vagal C-fibers via TRPA1 channel desensitization | Molecules. 2022 Nov 2;27(21):7465 |
ICR mice | LPS-induced sepsis-associated liver injury model | Oral | 20 mg/kg | 7 consecutive days | To investigate the protective effect of 6-Shogaol on LPS-induced liver injury. Results showed that 6-Shogaol significantly improved liver function markers (ALT and AST), enhanced antioxidant enzyme activities (SOD and CAT), reduced MDA levels, and alleviated inflammatory response by inhibiting the MAPK/NF-κB pathway. | Nutrients. 2021 Sep 28;13(10):3427 |
C57BL/6J mice | Methionine- and choline-deficient (MCD) dietary model of NASH | Intraperitoneal injection | 20 mg/kg | Three times a week for four weeks | 6-Shogaol effectively mitigated liver injury, inflammation, and fibrosis in MCD diet-fed mice by inhibiting oxidative stress, cell death, and endoplasmic reticulum stress. | Molecules. 2024 Jan 15;29(2):419 |
Mice | Cisplatin-induced acute kidney injury model | Intraperitoneal injection | 20 mg/kg | Once daily for 3 consecutive days | To evaluate the protective effect of 6-Shogaol on cisplatin-induced acute kidney injury. Results showed that 6-Shogaol ameliorated renal dysfunction and tubular injury, reduced oxidative stress, cell death, and inflammatory responses. | Molecules. 2021 Sep 30;26(19):5931 |
BALB/c nude mice | Ovarian cancer xenograft model | Intraperitoneal injection | 40 mg/kg and 60 mg/kg | Once a day for two days | 6-shogaol at 40 mg/kg and 60 mg/kg indicated lower tumor volumes compared with the control. The body weight of all groups was not significant. | Int J Mol Sci. 2023 Jan 30;24(3):2639 |
NOD/SCID nude mice | U937 xenograft model | Intraperitoneal injection | 50 mg/kg | Once daily for 20 days | Inhibited tumor growth of U937 xenograft and induced apoptosis in tumor cells | Mol Cancer. 2013 Nov 12;12(1):135 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03698318 | Healthy Subject | Not Applicable | Recruiting | April 2019 | France ... More >> Biofortis Mérieux Nutrisciences Recruiting Saint-Herblain, France, 44800 Contact: Sophie Schmid +33(0)240205799 sophie.schmid@mxns.com Less << |
Tags: Shogaol | [6]-Shogaol | 6-Shogaol | Autophagy | inhibitor | 555-66-8 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL